Intellia Therapeutics (NTLA)
NASDAQ:NTLA
Intellia Therapeutics (NTLA) Ownership Overview
1.80% Insiders
17.42% Mutual Funds
0.20% Other Institutional Investors
28.44% ETFs
52.13% Public Companies and Individual Investors
The ownership structure of Intellia Therapeutics (NTLA) stock is a mix of institutional, retail, and individual investors. Approximately 46.07% of the company’s stock is owned by Institutional Investors, 1.80% is owned by Insiders, and 52.13% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 03, 2026 | xxxxxxxxxxxxx | $8364 | |
Jan 07, 2026 | xxxxxxxxxxxxx | $27529 | |
Jan 07, 2026 | xxxxxxxxxxxxx | $314485 | |
Jan 07, 2026 | xxxxxxxxxxxxx | $1402500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $263820 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $2006262 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $127723842 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,207,324 | Institution | 12.03% | 191,656,801 | |
| 9,962,070 | Institution | 8.43% | 134,388,324 | |
| 9,818,500 | Institution | 8.31% | 132,451,565 | |
| 9,010,536 | Institution | 7.63% | 121,552,131 | |
| 4,988,032 | Institution | 4.22% | 67,288,552 | |
| 4,717,396 | Institution | 3.99% | 63,637,672 | |
| 2,746,674 | Institution | 2.33% | 37,052,632 | |
| 1,974,023 | Institution | 1.67% | 26,629,570 | |
| 1,726,466 | Institution | 1.46% | 23,290,026 | |
| 1,132,731 | Institution | 0.96% | 15,280,541 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,010,536 | Institution | 7.63% | 121,552,131 | |
| 1,974,023 | Institution | 1.67% | 26,629,570 | |
| 1,726,466 | Institution | 1.46% | 23,290,026 | |
| 1,132,731 | Institution | 0.96% | 15,280,541 | |
| 1,078,308 | Institution | 0.91% | 14,546,375 | |
| 850,895 | Institution | 0.72% | 11,478,574 | |
| 558,797 | Institution | 0.47% | 7,538,172 | |
| 507,376 | Institution | 0.43% | 6,844,502 | |
| 383,927 | Institution | 0.32% | 5,179,175 | |
| 356,275 | Institution | 0.30% | 4,806,150 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,097,247 | Institution | 7.70% | 122,721,862 | |
| 4,155,219 | Institution | 3.52% | 57,466,679 | |
| 3,640,982 | Institution | 3.08% | 50,172,732 | |
| 2,631,291 | Institution | 2.23% | 36,259,190 | |
| 2,618,478 | Institution | 2.22% | 35,323,268 | |
| 1,458,416 | Institution | 1.23% | 20,096,972 | |
| 1,266,847 | Institution | 1.07% | 17,457,152 | |
| 935,629 | Institution | 0.79% | 12,621,635 | |
| 841,413 | Institution | 0.71% | 11,350,661 | |
| 560,873 | Institution | 0.47% | 7,756,874 |
FAQ
Who Owns Intellia Therapeutics (NTLA)?
According to the latest TipRanks data, approximately 0.20% of the company's stock is held by institutional investors, 1.80% is held by insiders, and 52.13% is held by retail investors.
What percentage of Intellia Therapeutics (NTLA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.20% of Intellia Therapeutics (NTLA) stock is held by institutional investors.
What percentage of Intellia Therapeutics (NTLA) stock is held by retail investors?
According to the latest TipRanks data, approximately 52.13% of Intellia Therapeutics (NTLA) stock is held by retail investors.
Who owns the most shares of Intellia Therapeutics (NTLA)?
Cathie Wood owns the most shares of Intellia Therapeutics (NTLA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.